Clinical trial considerations: Why diversity matters…
February 15, 2024 | Diversity, Inclusion, clinical trials
Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here’s why diversity matters…
Clinical trials are crucial for understanding diseases and developing new treatments. For trials to truly benefit everyone, diversity among participants is key. But why does diversity matter?
Accurate results – Everyone’s genes, environment and lifestyles are different. Which is why it’s important that participants from different locations, and with differing ways of living are included; it helps in understanding how different populations may respond to treatment.
Health equity – Achieving health equity involves addressing social, economic and environmental factors that impact health outcomes. The principle behind health equity is that everyone should have the same access to healthcare, regardless of their background, race, ethnicity or circumstances, giving them a fair opportunity to be as healthy as possible.
Builds trust – Having a diverse representation of people participating in clinical trials helps to boost trust between healthcare providers, researchers and communities.
Hopefully we can agree that diversity in clinical trials is vitally important! So how can we ensure individuals feel seen, heard and respected? Here are a few things we always keep in mind when developing clinical trial support materials:
- Patient engagement – It’s important to fully understand the patient population we are creating for. By meeting with real people, there is potential to learn more about barriers to participation and what we can do to overcome them. For patients from diverse communities, we also consider different perceptions, the use of language and how information is received and acted upon. In our experience, the best way to do this is to engage with patients and ask for their feedback at every step of the process.
- Removing barriers – Some people face significant barriers that prevent them from being able to participate in a trial. These could be not having access to a local treatment centre or no way to get to a treatment centre if there is one. Financial burdens may also prevent someone from being able to take time out of work to take part in a trial or having the money to get to and from study visits. Digitalising trials can help to overcome some of these barriers by allowing patients to receive treatment, tests and assessments at home. Want to know more about how we can support you in navigating new digital strategies for clinical trials? We wrote a blog on this very topic!
- Create materials that represent a wide range of people – We ensure that variations in race, culture, age, gender, ethnicity, sexuality, and ability within any given target audience are always represented. And we do this via visual style or imagery, the words we use and how we localise the content, as well as the format of materials:
- Imagery – It can be difficult to achieve representative diversity in the imagery we use when there is such a range of body types and skin tones across the world. However, difficult doesn’t mean impossible. We recommend using illustrations as stylistically, they are better able to convey diversity.
- Localisation – In many cases, there may not be a one-size-fits-all approach to achieving diverse representation. This is why we never consider development of a single material to be sufficient. Instead, support materials should always be localised for all countries the study is planned for.
This doesn’t just mean translating the content though. It’s essential to also account for cultural adaptations that may be needed. Such as, are there technical limitations in some of your target countries? Do regional differences mean that some content may not be relatable across the board?
For example, here is how we created alternative food-related content for Latin America versus a more typical Western diet:
Diversity in clinical trials matters. Making sure participants feel represented matters. And representing diversity in clinical trial materials definitely matters. If you would like help in making sure every individual involved in your trial feels seen and appreciated, let’s talk.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Why patient engagement must come first in rare disease trials
Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients' lives to build trust and improve outcomes.
New Cuttsy+Cuttsy research shows why site support matters more than ever
Cuttsy+Cuttsy's upcoming report, 'The site factor: Where protocol meets practice in clinical trials', delves into the critical role of site staff in clinical research, offering insights into their daily challenges,...
Cuttsy+Cuttsy becomes employee owned
Cuttsy+Cuttsy announces its transition to employee ownership, celebrating 15 years of prioritising clients, patients, and its team while continuing under the leadership of founders Caroline Benson and Mathew Cutts.
Clinical research in 2026: The trends shaping tomorrow
Discover the key trends shaping clinical research in 2026, from patient-centric approaches to empowering site staff and fostering stronger human connections.
From overwhelming to actionable: Bringing lifestyle guidance to life
Discover how clear communication and health literacy principles can transform complex patient materials into simple, engaging, and empowering health information.
Behind the scenes: why we created ‘The participation equation’
Go behind the scenes of The participation equation – our call to put people, not just data, at the heart of clinical research.
Cuttsy+Cuttsy launches R:SQD – a new way to predict and improve trial success
Cuttsy+Cuttsy has launched R:SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and improve participant engagement and trial outcomes.
New report, The participation equation, uncovers key drivers of patient engagement in clinical trials
Cuttsy+Cuttsy’s new report, The participation equation, uncovers what drives patient engagement and retention in modern clinical trials through insights from over 700 participants and industry experts.
Why patients drop out of weight management trials and what you can do about it
Discover the key barriers to retention in obesity and weight-management trials and explore actionable, patient-centered strategies to improve engagement, outcomes, and data reliability.
Cuttsy+Cuttsy welcomes new team members
Cuttsy+Cuttsy is excited to announce the addition of three talented professionals to the team: Flo, an enthusiastic Account Executive; Vicki, a creative Graphic Designer; and Jo, a detail-driven Artworker